Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OF4A
|
|||
| Former ID |
DIB016067
|
|||
| Drug Name |
SART3 peptide cancer vaccine
|
|||
| Synonyms |
Colorectal cancer vaccine, Kurume University; SART3 peptide cancer vaccine, Kurume University; Vaccine (colorectal cancer), Kurume University
Click to Show/Hide
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 1 | [1], [2] | |
| Company |
Kurume University
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with ... Cancer Immunol Immunother. 2007 May;56(5):689-98. | |||
| REF 2 | Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancer. J Immunother. 2002 Sep-Oct;25(5):439-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.